341
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Phrenic nerve conduction studies as a biomarker of respiratory insufficiency in amyotrophic lateral sclerosis

, , , , , & show all
Pages 213-220 | Received 19 Jun 2015, Accepted 31 Aug 2015, Published online: 30 Nov 2015

References

  • Baumann F, Henderson RD, Morrison SC, Brown M, Hutchinson N, Douglas JA, et al. Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:194–202.
  • Radunovic A, Annane D, Rafiq MK, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2013 Mar 28;3:CD004427.
  • Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73:1227–33.
  • Lechtzin N, Rothstein J, Clawson L, Diette GB, Wiener CM. Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3:5–13.
  • Davis JN. Phrenic nerve conduction in man. J Neurol Neurosurg Psychiatry. 1967;30:420–6.
  • Bolton CF. Phrenic nerve conduction studies: technical aspects and normative data. Muscle Nerve. 2008;38:1658–9.
  • Pinto S, Turkman A, Pinto A, Swash M, de Carvalho M. Predicting respiratory insufficiency in amyotrophic lateral sclerosis: the role of phrenic nerve studies. Clin Neurophysiol. 2009;120:941–6.
  • Pinto S, Pinto A, de Carvalho M. Phrenic nerve studies predict survival in amyotrophic lateral sclerosis. Clin Neurophysiol. 2012;123:2454–9.
  • England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, et al. Practice parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009;72:185–92
  • Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
  • Bruijin L, Cudkowicz M; ALS Clinical Trials Working Group. Opportunities for improving therapy development in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:169–73
  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.
  • Quadrelli S, Roncoroni A, Montiel G. Assessment of respiratory function: influence of spirometry reference values and normality criteria selection. Respir Med. 1999;93:523–35.
  • Clanton TL, Diaz PT. Clinical assessment of the respiratory muscles. Phys Ther. 1995;75:983–95.
  • Chaudri MB, Liu C, Watson L, Jefferson D, Kinnear WJ. Sniff nasal inspiratory pressure as a marker of respiratory function in motor neuron disease. Eur Respir J. 2000;15:539–42.
  • Resman-Gaspersc A, Podnar S. Phrenic nerve conduction studies: technical aspects and normative data. Muscle Nerve. 2008;37:36–41.
  • Mier-Jedrzejowicz A, Brophy C, Moxham J, Green M. Assessment of diaphragm weakness. Am Rev Respir Dis. 1988;137:877–83.
  • Cohen CA, Zagelbaum G, Gross D, Roussos C, Macklem PT. Clinical manifestations of inspiratory muscle fatigue. Am J Med. 1982;73:308–16.
  • Pinto S, Geraldes R, Vaz N, Pinto A, de Carvalho M. Changes in the phrenic nerve motor response in amyotrophic lateral sclerosis: longitudinal study. Clinical Neurophysiology. 2009;120:2082–5.
  • Czaplinski A, Yen AA, Appel SH. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry. 2006;77:390–2.
  • Stambler N, Charatan M, Cedarbaum JM. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology. 1998;50:66–72.
  • Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello R. Use of sniff-nasal inspiratory force to predict survival in amyotrophic lateral sclerosis. AJRCCM 2005;171:269–74.
  • Bromberg MB, Forshew DA, Nau KL, Bromberg J, Simmons Z, Fries TJ. Motor unit number estimation, isometric strength, and electromyographic measures in amyotrophic lateral sclerosis. Muscle Nerve. 1993;16:1213–9.
  • Munsat TL, Andres PL, Finison L, Conlon T, Thibodeau L. The natural history of motor neuron loss in amyotrophic lateral sclerosis. Neurology. 1998;38:409–13.
  • Beasley WC. Quantitative muscle testing: principles and applications to research and clinical services. Arch Phys Med Rehabil. 1961;42:398–425.
  • Kelly JJ Jr, Thibodeau L, Andres PL, Finison LJ. Use of electrophysiologic tests to measure disease progression in ALS therapeutic trials. Muscle Nerve. 1990;13:471–9.
  • Lewelt A, Krosschell KJ, Scott C, Sakonju A, Kissel JT, Crawford TO, et al. Compound muscle action potential and motor function in children with spinal muscular atrophy. Muscle Nerve. 2010;42:703–8
  • Scelsa SN, Berger AR, Herskovitz S. Electrophysiologic correlates of weakness in L5/S1 radiculopathy. Electromyogr Clin Neurophysiol. 2001;41:145–51.
  • Komyathy K. Neal S, Feely S, Miller LJ, Lewis RA, et al. Anterior tibialis CMAP amplitude correlations with impairment in CMT1A. Muscle Nerve. 2013;47:493–6.
  • de Troyer A1, Boriek AM. Mechanics of the respiratory muscles. Compr Physiol. 2011;1:1273–300.
  • Lechtzin N, Scott Y, Busse AM, Clawson LL, Kimball R, Wiener CM. Early use of non-invasive ventilation prolongs survival in subjects with ALS. Amyotroph Lateral Scler. 2007;8:185–8.
  • Medicare: Local coverage determination (LCD): respiratory assist devices (L11504). http://www.medicarenhic.com/viewdoc.aspx?id=2350
  • Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS): revised report of an EFNS task force. J Neurol. 2012;19:360–75.
  • Kwon S, Min JH, Cho HJ, Joo BE, Cho EB, Seok JM, et al. Usefulness of phrenic latency and forced vital capacity in patients with ALS with latent respiratory dysfunction. Clin Neurophysiol. 2014; S1388-2457(14) 00537–9.
  • Bauer M1, Czell D, Hartmann S, Goldman B, Müller D, Weber M. Limitations of sniff nasal pressure as an outcome measurement in amyotrophic lateral sclerosis patients in a clinical trial. Respiration. 2012;84:306–11. Epub 2012 Jul 28.
  • Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain. 2001;124:2000–13.
  • Larson JL, Covey MK, Vitalo CA, Alex CG, Patel M, Kim MJ. Maximal inspiratory pressure. Learning effect and test-retest reliability in patients with chronic obstructive pulmonary disease. Chest. 1993;104:448–53.
  • Pinto S, de Carvalho M. Symmetry of phrenic nerve motor response in amyotrophic lateral sclerosis. Muscle Nerve. 2010;42:822–5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.